Alcon (ALC) Gains from Equity Investments (2018 - 2024)
Alcon (ALC) posted quarterly Gains from Equity Investments of $1.3 billion for Q2 2024, up 14.64% year-on-year from $1.2 billion in Q3 2023, and up 1.37% on a QoQ basis from $1.3 billion in Q1 2024.
Alcon (ALC) Gains from Equity Investments (2018 - 2024) Analysis & Trends
Alcon (ALC) has reported Gains from Equity Investments for 7 consecutive years, with $1.3 billion the latest figure, recorded in Q2 2024.
- Quarterly Gains from Equity Investments rose 14.64% year-over-year to $1.3 billion in Q2 2024, while the trailing twelve-month figure through Jun 2024 was $1.3 billion (up 14.64% YoY) and the FY2023 annual result came in at $1.1 billion, up 11.7% from the prior year.
- Gains from Equity Investments climbed to $1.3 billion in Q2 2024 per ALC's latest filing, from $1.3 billion in the prior quarter.
- Over the last five years, Gains from Equity Investments for ALC reached as high as $1.3 billion in Q2 2024 and fell as low as $611.0 million in Q1 2020.
- A 5-year average of $1.1 billion and a median of $1.2 billion in 2021 frame the typical range for Gains from Equity Investments.
- Annual changes were most pronounced in 2020 — Gains from Equity Investments tumbled 58.03% — and 2021, when it soared 105.9%.
- Year by year, Gains from Equity Investments stood at $1.3 billion in 2020, then increased by 1.55% to $1.3 billion in 2021, then decreased by 26.32% to $966.0 million in 2022, then gained by 11.7% to $1.1 billion in 2023, then increased by 23.35% to $1.3 billion in 2024.
- According to Business Quant data, Gains from Equity Investments over the past three periods registered $1.3 billion, $1.3 billion, and $1.1 billion for Q2 2024, Q1 2024, and Q4 2023 respectively.
Peer Comparison
| # | Company | Market Cap | Enterprise Value | Gross Profit (Qtr) |
|---|---|---|---|---|
| 1 | Intuitive Surgical | 126.11 Bn | 120.90 Bn | 1.96 Bn |
| 2 | Becton Dickinson | 44.96 Bn | 44.15 Bn | 2.15 Bn |
| 3 | Alcon | 33.16 Bn | 31.50 Bn | 1.53 Bn |
| 4 | Medline | 33.00 Bn | 30.76 Bn | 1.84 Bn |
| 5 | Resmed | 29.51 Bn | 27.85 Bn | 890.98 Mn |
| 6 | West Pharmaceutical Services | 23.50 Bn | 23.06 Bn | 329.20 Mn |
| 7 | Solventum | 14.07 Bn | 13.51 Bn | 1.10 Bn |
| 8 | Cooper Companies | 13.92 Bn | 13.78 Bn | 735.40 Mn |
| 9 | Align Technology | 12.14 Bn | 11.08 Bn | 736.59 Mn |
| 10 | Baxter International | 11.99 Bn | 9.98 Bn | 891.00 Mn |
Historic Data
Download Data| Date | Value |
|---|---|
| Jun 30, 2024 | 1.33 Bn |
| Jun 30, 2024 | 1.33 Bn |
| Mar 31, 2024 | 1.31 Bn |
| Mar 31, 2024 | 1.31 Bn |
| Dec 31, 2023 | 1.08 Bn |
| Dec 31, 2023 | 1.08 Bn |
| Jun 30, 2023 | 1.16 Bn |
| Jun 30, 2023 | 1.16 Bn |
| Mar 31, 2023 | 1.22 Bn |
| Mar 31, 2023 | 1.22 Bn |
| Dec 31, 2022 | 966.00 Mn |
| Dec 31, 2022 | 966.00 Mn |
| Sep 30, 2022 | 942.00 Mn |
| Sep 30, 2022 | 942.00 Mn |
| Jun 30, 2022 | 1.31 Bn |
| Jun 30, 2022 | 1.31 Bn |
| Mar 31, 2022 | 900.00 Mn |
| Mar 31, 2022 | 900.00 Mn |
| Dec 31, 2021 | 1.31 Bn |
| Dec 31, 2021 | 1.31 Bn |